Encore Global Management »

Royalty Pharma shares owned by Encore Global Management

Quarter-by-quarter ownership of Royalty Pharma (RPRX) shares owned by Encore Global Management from 13F filings

Historical chart of Encore Global Management investment in Royalty Pharma

Tip: Access up to 7 years of quarterly data

All positions including Royalty Pharma held by Encore Global Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Royalty Pharma by Encore Global Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $112k 2.0k 56.07

More positions owned by Encore Global Management

Microsoft Corporation (MSFT)
Palo Alto Networks (PANW)
Meta Platforms Cl A (META)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Thermo Fisher Scientific (TMO)
Qualcomm (QCOM)
salesforce (CRM)
Charter Communications Cl A (CHTR)
Advanced Micro Devices (AMD)
Okta Cl A (OKTA)
Regeneron Pharmaceuticals (REGN)
Boston Scientific Corporation (BSX)
Marvell Technology (MRVL)
Servicenow (NOW)

View all positions for Encore Global Management

Top funds holding Royalty Pharma

Morgan Stanley
Capital Research and Management Company - Division 3
BlackRock
FMR
State Street Corporation
Swedbank AB
Baillie Gifford & Co
Geode Capital Management
Capital World Investors
Caledonia
Norges Bank Investment Management
Vanguard Capital Management
Northern Trust
Royal London Asset Management
AQR Capital Management

View all funds holding Royalty Pharma